Matinas BioPharma Investor Presentation Deck

10 Results of EnACT Published in Highly-Regarded Peer-Reviewed Journal Clinical Infectious Diseases MAJOR ARTICLE IDSA hivma hiv medicine association Infectious Diseases Society of America Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial OXFORD David R. Boulware, Mucunguzi Atukunda, Enock Kagimu,² Abdu K. Musubire, Andrew Akampurira,² Lillian Tugume, Kenneth Ssebambulidde, John Kasibante, Laura Nsangi,² Timothy Mugabi, Jane Gakuru,² Sarah Kimuda, Derrick Kasozi,² Suzan Namombwe,² Isaac Turyasingura,² Morris K. Rutakingirwa, Edward Mpoza,² Enos Kigozi,* Conrad Muzoora, Jayne Ellis, Caleb P. Skipper, Theresa Matkovits, Peter R. Williamson,³ Darlisha A. Williams, Ann Fieberg, Kathy H. Hullsiek, Mahsa Abassi, Biyue Dai, and David B. Meya¹2 6 1 ¹Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA; Infectious Diseases Institute, Makerere University, Kampala, Uganda; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA; *Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda: "Matinas Biopharma Nanotechnologies, Bedminster, New Jersey, USA; and "Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA COPYRIGHT MATINAS BIOPHARMA 2024 MATINAS BIOPHARMA

View entire presentation